Cargando…
Effectiveness of gene delivery systems for pluripotent and differentiated cells
Human embryonic stem cells (hESC) and induced pluripotent stem cells (hiPSC) assert a great future for the cardiovascular diseases, both to study them and to explore therapies. However, a comprehensive assessment of the viral vectors used to modify these cells is lacking. In this study, we aimed to...
Autores principales: | Rapti, Kleopatra, Stillitano, Francesca, Karakikes, Ioannis, Nonnenmacher, Mathieu, Weber, Thomas, Hulot, Jean-Sebastian, Hajjar, Roger J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4449028/ https://www.ncbi.nlm.nih.gov/pubmed/26052535 http://dx.doi.org/10.1038/mtm.2014.67 |
Ejemplares similares
-
Considerations for pre-clinical models and clinical trials of pluripotent stem cell-derived cardiomyocytes
por: Hulot, Jean-Sébastien, et al.
Publicado: (2014) -
Modeling susceptibility to drug-induced long QT with a panel of subject-specific induced pluripotent stem cells
por: Stillitano, Francesca, et al.
Publicado: (2017) -
2525 Development of human cell-based screening assays to detect subject-specific drug-response variability
por: Stillitano, Francesca, et al.
Publicado: (2018) -
3444 Development of human engineered cardiac tissue (hECT)-based screening assay to explore cardiac contractile properties in response to pharmacological challenge with proarrhythmic drugs
por: Stillitano, Francesca, et al.
Publicado: (2019) -
Functional Human Beige Adipocytes From Induced Pluripotent Stem Cells
por: Guénantin, Anne-Claire, et al.
Publicado: (2017)